首页> 外文期刊>Digestive Diseases and Sciences >Fecal and Mucosa-Associated Intestinal Microbiota in Patients with Diarrhea-Predominant Irritable Bowel Syndrome
【24h】

Fecal and Mucosa-Associated Intestinal Microbiota in Patients with Diarrhea-Predominant Irritable Bowel Syndrome

机译:腹泻患者粪便和粘膜相关肠道微生物症患者患者

获取原文
获取原文并翻译 | 示例
           

摘要

Background Irritable bowel syndrome (IBS) has been associated with changes in the intestinal microbiota. Only a few studies have explored differences in the mucosa-associated microbiota between IBS patients and healthy controls (HC). Aims To characterize and compare the microbiota in mucosal and fecal samples from carefully selected patients with IBS-D and HC. Methods The cohort was composed of 23 diarrhea-predominant IBS (IBS-D) patients and 24 HC. Fresh stool samples were collected from participants prior to the collection of colonic mucosal samples from an unprepped bowel. After DNA extraction, 16S rRNA genes were sequenced by 454 pyrosequencing and analyzed using the QIIME pipeline. Results The fecal microbiota (luminal niche) of IBS-D patients was found to have reduced enteric richness compared to HC ( P ? ?25% samples of either niche. Conclusion Fecal and mucosal microbiota of IBS-D patients and HC are very similar and are not sufficient to explain the reported altered physiology and symptomatology of IBS-D. Future studies should investigate intestinal microbiome-dependent functional activity in addition to the fecal and mucosal-associated microbial composition.
机译:背景技术肠易激综合征(IBS)与肠道微生物群的变化有关。在IBS患者和健康对照(HC)之间只有几项研究探讨了粘膜相关微生物群的差异。旨在表征和比较粘膜和粪便样本中的微生物,从精心挑选的IBS-D和HC患者。方法队列由23例腹泻,患者组成23例,患者和24核苷酸。在从未分娩的肠道收集结肠粘膜样品之前,从参与者收集新鲜粪便样本。 DNA提取后,将16S rRNA基因通过454焦点测序测序并使用Qiime管道分析。结果发现IBS-D患者的粪便微生物群(腔NICHE)与HC相比,肠道浓度降低了不足以解释报告的改变的IBS-D的生理学和症状学。未来的研究除了粪便和粘膜相关的微生物组合物外,还应研究肠道微生物组依赖性功能活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号